Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphomatous Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04605315
What this trial is testing

Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma

Who this might be right for
Pediatric ALLStone, Urinary
Azienda Ospedaliero-Universitaria di Parma 70
Not applicableUnknownNCT04491825
What this trial is testing

Diagnostic Classifier for Cutaneous T-cell Lymphomas

Who this might be right for
CTCL/ Mycosis Fungoides
Medical University of Vienna 160
Not applicableUnknownNCT06106776
What this trial is testing

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Who this might be right for
Lymphoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Early research (Phase 1)Study completedNCT05149391
What this trial is testing

C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma

Who this might be right for
B Cell Non-Hodgkin's Lymphoma
Peking University 3
Not applicableEnded earlyNCT05410574
What this trial is testing

Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Washington University School of Medicine 17
Large-scale testing (Phase 3)UnknownNCT00091676
What this trial is testing

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Biovest International 629
Early research (Phase 1)Looking for participantsNCT05773040
What this trial is testing

JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Who this might be right for
LymphomasB-cell Lymphomas
M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Looking for participantsNCT06006117
What this trial is testing

Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
The Lymphoma Academic Research Organisation 260
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06686108
What this trial is testing

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableEnded earlyNCT02704689
What this trial is testing

AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY

Who this might be right for
Degenerative Disc DiseaseSpondylolisthesis, Grade 1Retrolisthesis
VB Spine, LLC 9
Testing effectiveness (Phase 2)Ended earlyNCT04517435
What this trial is testing

ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Deepa Jagadeesh 13
Testing effectiveness (Phase 2)WithdrawnNCT05604417
What this trial is testing

Zandelisib + Tazemetostat in R/R Follicular Lymphoma

Who this might be right for
Relapsed Follicular LymphomaRefractory Follicular Lymphoma
Jacob Soumerai, MD
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Early research (Phase 1)Ended earlyNCT03435250
What this trial is testing

Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

Who this might be right for
Advanced Solid TumorsLymphoma
Institut de Recherches Internationales Servier 123
Early research (Phase 1)UnknownNCT05900089
What this trial is testing

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Very early researchUnknownNCT05239676
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Who this might be right for
Lymphoma
Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT00136474
What this trial is testing

Amifostine for Head and Neck Irradiation in Lymphoma

Who this might be right for
LymphomaHodgkin's DiseaseNon-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 75
Early research (Phase 1)Study completedNCT01614197
What this trial is testing

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma
Therapeutic Advances in Childhood Leukemia Consortium 16
Next Page